Literature DB >> 26640775

A computational model to monitor and predict trends in bacterial resistance.

Ali Alawieh1,2, Zahraa Sabra2, Abdul Rahman Bizri3, Christopher Davies4, Roger White5, Fadi A Zaraket2.   

Abstract

Current concern over the emergence of multidrug-resistant superbugs has renewed interest in approaches that can monitor existing trends in bacterial resistance and make predictions of future trends. Recent advances in bacterial surveillance and the development of online repositories of susceptibility tests across wide geographical areas provide an important new resource, yet there are only limited computational tools for its exploitation. Here we propose a hybrid computational model called BARDmaps for automated analysis of antibacterial susceptibility tests from surveillance records and for performing future predictions. BARDmaps was designed to include a structural computational model that can detect patterns among bacterial resistance changes as well as a behavioural computational model that can use the detected patterns to predict future changes in bacterial resistance. Data from the European Antimicrobial Resistance Surveillance Network (EARS-Net) were used to validate and apply the model. BARDmaps was compared with standard curve-fitting approaches used in epidemiological research. Here we show that BARDmaps can reliably predict future trends in bacterial resistance across Europe. BARDmaps performed better than other curve-fitting approaches for predicting future resistance levels. In addition, BARDmaps was also able to detect abrupt changes in bacterial resistance in response to outbreaks and interventions as well as to compare bacterial behaviour across countries and drugs. In conclusion, BARDmaps is a reliable tool to automatically predict and analyse changes in bacterial resistance across Europe. We anticipate that BARDmaps will become an invaluable tool both for clinical providers and governmental agencies to help combat the threat posed by antibiotic-resistant bacteria.

Entities:  

Keywords:  Antimicrobial resistance; Computational modelling; Resistance monitoring

Year:  2015        PMID: 26640775      PMCID: PMC4666607          DOI: 10.1016/j.jgar.2015.04.006

Source DB:  PubMed          Journal:  J Glob Antimicrob Resist        ISSN: 2213-7165            Impact factor:   4.035


  24 in total

1.  ECDC's growing responsibilities in defending Europe against infectious diseases.

Authors:  B Duncan; A Würz
Journal:  Infection       Date:  2006-12       Impact factor: 3.553

2.  Trends in antimicrobial resistance in Europe: update of EARSS results.

Authors:  M de Kraker; N van de Sande-Bruinsma
Journal:  Euro Surveill       Date:  2007-03-15

Review 3.  Antimicrobial resistance in Europe and its potential impact on empirical therapy.

Authors:  G M Rossolini; E Mantengoli
Journal:  Clin Microbiol Infect       Date:  2008-12       Impact factor: 8.067

4.  A call to arms: the imperative for antimicrobial stewardship.

Authors:  John G Bartlett
Journal:  Clin Infect Dis       Date:  2011-08       Impact factor: 9.079

5.  Hospital outbreak of Klebsiella pneumoniae resistant to broad-spectrum cephalosporins and beta-lactam-beta-lactamase inhibitor combinations by hyperproduction of SHV-5 beta-lactamase.

Authors:  G L French; K P Shannon; N Simmons
Journal:  J Clin Microbiol       Date:  1996-02       Impact factor: 5.948

Review 6.  Horizontal gene transfer and the genomics of enterococcal antibiotic resistance.

Authors:  Kelli L Palmer; Veronica N Kos; Michael S Gilmore
Journal:  Curr Opin Microbiol       Date:  2010-09-15       Impact factor: 7.934

Review 7.  Meticillin-resistant Staphylococcus aureus (MRSA): global epidemiology and harmonisation of typing methods.

Authors:  Stefania Stefani; Doo Ryeon Chung; Jodi A Lindsay; Alex W Friedrich; Angela M Kearns; Henrik Westh; Fiona M Mackenzie
Journal:  Int J Antimicrob Agents       Date:  2012-01-09       Impact factor: 5.283

Review 8.  Mandatory surveillance of methicillin-resistant Staphylococcus aureus (MRSA) bacteraemia in England: the first 10 years.

Authors:  Alan P Johnson; John Davies; Rebecca Guy; Julia Abernethy; Elizabeth Sheridan; Andrew Pearson; Georgia Duckworth
Journal:  J Antimicrob Chemother       Date:  2012-01-04       Impact factor: 5.790

Review 9.  Extended-spectrum beta-lactamases: a clinical update.

Authors:  David L Paterson; Robert A Bonomo
Journal:  Clin Microbiol Rev       Date:  2005-10       Impact factor: 26.132

Review 10.  Lessons learnt after the introduction of the seven valent-pneumococcal conjugate vaccine toward broader spectrum conjugate vaccines.

Authors:  Oana Falup-Pecurariu
Journal:  Biomed J       Date:  2012 Nov-Dec       Impact factor: 4.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.